Gerresheimer at CPhI North America

Innovative packaging and easy administration of medications

57
Gerresheimer
When it comes to packaging, safely storing, and administering medications, biologics, and vaccines simply and sustainably, Gerresheimer

When it comes to packaging, safely storing, and administering medications, biologics, and vaccines simply and sustainably, Gerresheimer is always a good partner in the American market. At CphI North America from 10-12 August 2021, the company will be exhibiting primary packaging such as injection vials and other containers made of glass and plastic for solid and liquid medications as well as syringes that protect against needlestick injuries at booth 1313 in Pennsylvania Convention Center in Philadelphia.

Gerresheimer’s Gx Elite Vials

The Gx Elite vials are the result of a careful product development process spanning several years. The primary focus was to provide a Type I vial made of borosilicate glass that would be a safer product for the customer and the patient. The highly shatter-resistant vials are extremely durable, free of cosmetic defects, and can be customized for specialized customer requirements. Gx Elite Glass vials are produced using the quality by design (QbD) approach that creates a product that will exceed customers’ expectations. A combination of design, manufacturing and handling improvements along with specialized final packaging ensures that the vials can be supplied for end-to-end use on various filling lines. These types of improvements make it possible for customers to supply products to the market as needed and reduce costs for the industry. Gx Elite vials, which meet all existing regulatory requirements worldwide, are also available in RTF (ready-to-fill) format.

Ready for filling – Gx RTF Vials for clinical trials

The Gx RTF injection vials are made of borosilicate glass type I and meet all common requirements of the applicable ISO standards and pharmacopeias (USP and Ph. Eur.). They are formed in accordance with cGMP, washed in a clean room, packaged in trays or nests and tubs, and sterilized. Gerresheimer RTF vials are also supplied in the familiar Ompi EZ-fill or any other packaging format. This means they are ready for the next process steps in filling. The advantages are sterile delivery, a simplified filling and finishing process, the highest quality standards, flexibility thanks to various packaging configurations, and a wide range of filling and sealing technologies. This all adds up to an improvement in overall manufacturing costs over the product life cycle.

For your eyes only – Dropper bottle systems for ophthalmic drugs

Often it is only the small improvements that make a product ideal for the application. The design was developed specifically for the US market. Many people must take eye drops several times a day, so these bottles must work reliably until the last drop. One example is the new dropper bottle system E / F with different closure solutions – a closure where the tamper-evident ring (TE) remains attached to the bottle after opening (system E) and a sleeved cap (system F). They can be supplied already sterilized (gamma irradiated) or packaged for sterilization only.

RTU COP Vials for injectable and diagnostic products

RTU COP (Cyclic Olefin Polymer) vials combine the best features of plastic and glass packaging for liquid drugs. With their high break strength, inert resin material, and high transparency, they are an ideal packaging solution for cell and gene therapy products. The vials offer an inert contact surface and are said to have been proven in various pharmaceutical applications in the market. They also provide manufacturers of toxic or high potency drug solutions with a packaging safety feature. The monolayer plastic vials are offered in a standard ISO-like format in 2-, 5-, 10-, 50- and 100-milliliter sizes.

Gx InnoSafe: More safety from needlestick injuries

With their exposed needles, used syringes are an omnipresent source of danger in doctors’ surgeries, laboratories, and hospitals. With Gx InnoSafe, Gerresheimer now offers a syringe with an integrated, passive safety system that prevents unintentional needle-stick injuries.

Gx RTF ClearJect: Gerresheimer produces COP syringes in Germany

Gerresheimer presents its newly developed Gx RTF ClearJect brand: a COP syringe with cannula. The prefillable syringes are produced at the German plant in Pfreimd from the high-performance plastic COP (cyclo-olefin polymer) and are particularly suitable for sophisticated, sensitive medications and high-viscosity active ingredients.

Gerresheimer locations in North America and Mexico

Gerresheimer produces glass and plastic containers for the pharma industry in North America and Mexico at the following production sites:

Glass Innovation Center, Vineland, New Jersey

The technical center of excellence develops innovative solutions in primary packaging glass, technologies, and digitized processes to meet the evolving demand of the pharmaceutical industry.

Gerresheimer Glass, Vineland Plant, New Jersey

The Vineland plant produces Type I glass products, in both clear and amber. These products include dental and pharmaceutical cartridges, insulin pen cartridges, specialty and pharmaceutical vials, syringes, and innovative technology.

Gerresheimer Glass, Chicago Heights Plant, Illinois

Containers made of type I clear glass are produced here. The product range includes serum bottles, bottles with screw caps, IV bottles, and various other bottles made of container glass.

Gerresheimer Glass, Morganton Plant, North Carolina

The Morganton plant produces serum vials, large outer diameter vials, and double chamber vials in Type I glass in clear and amber.

Gerresheimer Glass, Forest Grove Plant/Vineland, New Jersey

Type I glass pharmaceutical containers in clear and amber are produced here. These are serum vials, vials with large outer diameter, vials for rapid cultivation, special vials, and cartridges.

Gerresheimer Querétaro S.A., Mexico

The Mexican plant produces ampoules, serum vials, screw-cap vials, ADD vantage vials, RTF syringes and vials, cartridges, onion skin tubes, and specialty products from Type I clear and amber glass and Type III amber glass.

Centor, Berlin Plant, Perrysburg, Ohio

Centor has been part of the Gerresheimer Group since 2015 and is a manufacturer of plastic containers for prescription medicines that meet regulatory requirements in the US end-customer market. Centor supplies nationwide and regional pharmacy chains, supermarkets, and wholesalers.

Gerresheimer Primary Packaging Plastic, Berlin, Ohio

Since May 2018, Gerresheimer Primary Packaging Plastic has been producing HDPE containers for tablets under cleanroom conditions in accordance with FDA regulations at the Centor Berlin plant. A new building to produce plastic containers for the pharma industry is currently being built here with class 8 cleanrooms on an area of around 6,000 square meters.

Gerresheimer Peachtree City, Medical Systems, Georgia

At the site in Peachtree City near Atlanta (Georgia), founded in 1993, customer-specific inhalers, test cards for microbiological test systems, various components for insulin delivery devices, and closures for ampoules are produced.

Gerresheimer is a global partner to the pharma and healthcare industry. With specialty products made of glass and plastic, the company contributes to health and well-being. Gerresheimer is represented worldwide and produces with around 10,000 employees wherever its customers and markets are. With plants in Europe, North and South America, and Asia, Gerresheimer generates sales of around EUR 1.4 billion (approximately Rs 12,372 crore). Its wide range of products includes pharmaceutical packaging and products for the simple and safe administration of medicines: Insulin pens, inhalers, micropumps, prefillable syringes, injection vials, ampoules, bottles, and containers for liquid and solid medications with closure and safety systems as well as packaging for the cosmetics industry.

As you join us today from India and elsewhere, we have a favour to ask. Through these times of ambiguity and challenge, the packaging industry in India and in most parts of the world has been fortunate. We are now read in more than 90 countries as our coverage widens and increases in impact. Our traffic as per analytics more than doubled in 2020 and many readers chose to support us financially even when advertising fell to pieces.

As we come out of the pandemic in the next few months, we hope to again expand our geography and evolve our high-impact reporting and authoritative and technical information, with some of the best correspondents in the industry. If there were ever a time to support us, it is now. You can power Packaging South Asia’s balanced industry journalism and help to sustain us by subscribing.

Subscribe Now

LEAVE A REPLY

Please enter your comment!
Please enter your name here